Anticancer agent 170
Anticancer agent 170 (compound 3a) is a keton derivative of Deguelin , and shows potency anti-cancer activity against A549, with the IC50 of 6.62 μM[1].
Product Specifications
CAS Number
24126-98-5
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-170.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(CC(C2=CC=C(O)C=C2O)=O)C=C1OC
Molecular Formula
C16H16O5
Molecular Weight
288.30
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]John Alfon P. Francisco, et al. Inhibitory Effects of B-, C-, and E-Ring-Truncated Deguelin Derivatives Against A549, HCT116, and MCF-7 Cancer Cells. ACS Omega 2023, 8, 45, 43109–43117
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
